On the other hand, several clinical cohort studies have indicated that lower circulating levels of Hb are associated with a higher risk of AD, thus suggesting that Hb may also exert endogenous protective effects during the progression of AD [143,144]. The gene discussed is GSTM1; the disease is Alzheimer disease.